Abstract

IntroductionRheumatoid arthritis (RA) is a heterogeneous disease and its underlying molecular mechanisms are still poorly understood. Because previous microarray studies have only focused on long-standing (LS) RA compared to osteoarthritis, we aimed to compare the molecular profiles of early and LS RA versus control synovia.MethodsSynovial biopsies were obtained by arthroscopy from 15 patients (4 early untreated RA, 4 treated LS RA and 7 controls, who had traumatic or mechanical lesions). Extracted mRNAs were used for large-scale gene-expression profiling. The different gene-expression combinations identified by comparison of profiles of early, LS RA and healthy synovia were linked to the biological processes involved in each situation.ResultsThree combinations of 719, 116 and 52 transcripts discriminated, respectively, early from LS RA, and early or LS RA from healthy synovia. We identified several gene clusters and distinct molecular signatures specifically expressed during early or LS RA, thereby suggesting the involvement of different pathophysiological mechanisms during the course of RA.ConclusionsEarly and LS RA have distinct molecular signatures with different biological processes participating at different times during the course of the disease. These results suggest that better knowledge of the main biological processes involved at a given RA stage might help to choose the most appropriate treatment.

Highlights

  • Rheumatoid arthritis (RA) is a heterogeneous disease and its underlying molecular mechanisms are still poorly understood

  • Early and long-standing RA (LS RA) have distinct molecular signatures with different biological processes participating at different times during the course of the disease

  • These results suggest that better knowledge of the main biological processes involved at a given RA stage might help to choose the most appropriate treatment

Read more

Summary

Introduction

Rheumatoid arthritis (RA) is a heterogeneous disease and its underlying molecular mechanisms are still poorly understood. Rheumatoid arthritis (RA) is a chronic, autoimmune, and inflammatory polyarthritis that induces joint damage and disability. It is a heterogeneous disease with different clinical presentations and courses, ranging from mild to severe. The few microarray studies available were conducted on human RA synovia from patients with long-standing (LS) disease and/ or treated with disease-modifying antirheumatic drugs (DMARDs) and/or glucocorticoids [2,3,4]. The molecular differences observed in those comparisons did not aRNA: antisense RNA; DMARD: disease-modifying antirheumatic drug; LS: long-standing; MHC: major histocompatibility complex; PANTHER: Protein ANalysis THrough Evolutionary Relationships; PBMC: peripheral blood mononuclear cell; RA: rheumatoid arthritis

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.